Cited by 4,360SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesImmune responses and vaccinations

The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.

The trinity of COVID-19: immunity, inflammation and intervention

Open access

Tay, Matthew Zirui, Poh, Chek Meng, Rénia, Laurent, MacAry, Paul A., Ng, Lisa F. P.·2020·Nature Reviews Immunology

DOI 10.1038/s41577-020-0311-8PMC PMC7187672

Open this paper in CoChat — free account Open PDF

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. Alongside investigations into the virology of SARS-CoV-2, understanding the fundamental physiological and immunological processes underlying the clinical manifestations of COVID-19 is vital for the identification and rational design of effective therapies. Here, we provide an overview of the pathophysiology of SARS-CoV-2 infection. We describe the interaction of SARS-CoV-2 with the immune system and the subsequent contribution of dysfunctional immune responses to disease progression. From nascent reports describing SARS-CoV-2, we make inferences on the basis of the parallel pathophysiological and immunological features of the other human coronaviruses targeting the lower respiratory tract - severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV). Finally, we highlight the implications of these approaches for potential therapeutic interventions that target viral infection and/or immunoregulation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41577-020-0311-8

Cites

139 of 139 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
Retracted
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575

Show all 136 references

Research works printed but not linked: 3

Pipeline Review. APEIRON’s respiratory drug product to start pilot clinical trial to treat coronavirus disease COVID-19 in China. Pipeline Review https://pipelinereview.com/index.php/2020022673884/Proteins-and-Peptides/APEIRONs-respiratory-drug-product-to-start-pilot-clinical-trial-to-treat-coronavirus-disease-COVID-19-in-China.html (2020).
Humanigen. Humanigen partners with CTI, a leading contract research organization, for planned phase III study for lenzilumab for coronavirus treatment. Humanigen https://www.humanigen.com/press/Humanigen-Partners-With-CTI%2C-A-Leading-Contract-Research-Organization%2C-For-Planned-Phase-III-Study-For-Lenzilumab-For-Coronavirus-Treatment (2020).
VIR. Press release details: Vir Biotechnology applying multiple platforms to address public health risk from Wuhan coronavirus. VIR https://investors.vir.bio/news-releases/news-release-details/vir-biotechnology-applying-multiple-platforms-address-public (2020).

Sorted by citations

Items 201–300 of 1,002

Expression of Concern: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
Sadeghi, A., Tahmasebi, S., Mahmood, A., Kuznetsova, M. S., Valizadeh, H., Taghizadieh, A., Nazemiyeh, M., Maleki, L. A., Jadidi‐Niaragh, F., Abbaspour‐Aghdam, S., et al. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30047 · Cited by 176
Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity
Hoagland, D. A., Møller, R., Uhl, S. A., Oishi, K., Frere, J. J., Golynker, I., Horiuchi, S., Panis, M., Blanco-Melo, D., Sachs, D. M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.01.017 · Cited by 177
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
Moll, G., Drzeniek, N. M., Kamhieh‐Milz, J., Geißler, S., Volk, H., & Reinke, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01091 · Cited by 176
Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report
Hollstein, T., Schulte, D. M., Schulz, J. C., Glück, A., Ziegler, A. G., Bonifacio, E. E., Wendorff, M., Franke, A., Schreiber, S., Bornstein, S. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-00281-8 · Cited by 181
Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes
Cevallos, E. C., Fuentes, X. F., Campioli, C. C., O’Horo, J. C., Saleh, O. A., Odeyemi, Y., Yadav, H., & Temesgen, Z. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.10.054 · Cited by 172
Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19
Rogero, M. M., Leão, M. D. C., Santana, T. M., Pimentel, M. V. D. M. B., Carlini, G. C. G., da Silveira, T. F. F., Gonçalves, R. C., & de Castro, I. A. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.005 · Cited by 181
“The identification of which factors could be associated with healthy versus dysfunctional outcomes is essential to better deal with SARS-CoV-2 infection [19], and can influence the action of drugs and supplements.”
High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents
Kanjanasirirat, P., Suksatu, A., Manopwisedjaroen, S., Munyoo, B., Tuchinda, P., Jearawuttanakul, K., Seemakhan, S., Charoensutthivarakul, S., Wongtrakoongate, P., Rangkasenee, N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77003-3 · Cited by 174
Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword
Tan, L. Y., Komarasamy, T. V., & Balasubramaniam, V. R. M. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.742941 · Cited by 184
The Lactate and the Lactate Dehydrogenase in Inflammatory Diseases and Major Risk Factors in COVID-19 Patients
Gupta, G. S. (2022) · Inflammation · doi:10.1007/s10753-022-01680-7 · Cited by 181
Single-cell RNA sequencing reveals SARS-CoV-2 infection dynamics in lungs of African green monkeys
Speranza, E. E., Williamson, B. N., Feldmann, F., Sturdevant, G. L., Pérez-Pérez, L., Meade-White, K. D., Smith, B. J., Lovaglio, J., Martens, C., Munster, V. J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe8146 · Cited by 160
Immunology of COVID‐19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
Sokołowska, M., Łukasik, Z. M., Agache, I. O., Akdiş, C. A., Akdiş, D., Akdiş, M., Barcik, W., Brough, H. A., Eiwegger, T., Eljaszewicz, A., et al. (2020) · Allergy · doi:10.1111/all.14462 · Cited by 170
COVID-19 Clinical Characteristics, and Sex-Specific Risk of Mortality: Systematic Review and Meta-Analysis
Nasiri, M. J., Haddadi, S., Tahvildari, A., Farsi, Y., Arbabi, M., Hasanzadeh, S., Jamshidi, P. K., Murthi, M., & Mirsaeidi, M. S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00459 · Cited by 170
A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)
Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D. L. A., Robert, A. R., & Noubiap, J. J. (2020) · Biomarker Research · doi:10.1186/s40364-020-00217-0 · Cited by 168
Neutrophils and COVID-19: The road so far
Silva, L. H. A. C., Carvalho, D. C. M., Lima, É. D. A., Galvão, J. G. F. M., da Silva, J. S. D. F., de Sales-Neto, J. M., & Rodrigues‐Mascarenhas, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107233 · Cited by 173
“disease caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) [1], a new type of coronavirus identified in China in”
Role of vitamins and minerals as immunity boosters in COVID-19
Kumar, P., Kumar, M., Bedi, O., Gupta, M., Kumar, S., Jaiswal, G., Rahi, V., Yedke, N. G., Bijalwan, A., Sharma, S., et al. (2021) · Inflammopharmacology · doi:10.1007/s10787-021-00826-7 · Cited by 177
Coronavirus Optimization Algorithm: A Bioinspired Metaheuristic Based on the COVID-19 Propagation Model
Alvarez, F. M., Cortés, G. A., Torres, J. F., Gutiérrez‐Avilés, D., Melgar-García, L., Pérez-Chacón, R., Rubio-Escudero, C., Riquelme, J. C., & Troncoso, A. (2020) · Big Data · doi:10.1089/big.2020.0051 · Cited by 165
COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
Sorokin, A. V., Karathanasis, S. K., Yang, Z., Freeman, L. A., Kotani, K., & Remaley, A. T. (2020) · The FASEB Journal · doi:10.1096/fj.202001451 · Cited by 170
Polysaccharides obtained from natural edible sources and their role in modulating the immune system: Biologically active potential that can be exploited against COVID-19
Barbosa, J. R., & de Carvalho, R. N. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.026 · Cited by 165
Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration
Chen, R., Lan, Z., Ye, J., Pang, L., Liu, Y., Wu, W., Qin, X., Guo, Y., & Zhang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.589095 · Cited by 165
Peripheral and lung resident memory T cell responses against SARS-CoV-2
Grau-Expósito, J., Sánchez-Gaona, N., Massana, N., Suppi, M., Astorga-Gamaza, A., Perea, D., Rosado, J., Falcó-Roget, A., Kirkegaard-Biosca, C., Torrella, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23333-3 · Cited by 169
Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment
Zhou, Y., Xu, J., Hou, Y., Leverenz, J. B., Kallianpur, A. R., Mehra, R., Liu, Y., Yu, H., Pieper, A. A., Jehi, L. E., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00850-3 · Cited by 165
Addressing male sexual and reproductive health in the wake of COVID-19 outbreak
Sansone, A., Mollaioli, D., Ciocca, G., Limoncin, E., Colonnello, E., Vena, W., & Jannini, E. A. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01350-1 · Cited by 170
MiR-29a-3p Improves Acute Lung Injury by Reducing Alveolar Epithelial Cell PANoptosis
Cui, Y., Wang, X., Lin, F., Li, W., Zhao, Y., Zhu, F., Yang, H., Rao, M., Li, Y., Liang, H., et al. (2022) · Aging and Disease · doi:10.14336/ad.2021.1023 · Cited by 160
Viral load of SARS-CoV-2 across patients and compared to other respiratory viruses
Jacot, D., Greub, G., Jaton, K., & Opota, O. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.08.004 · Cited by 159
SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties
Watson, A., Madsen, J., & Clark, H. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.622598 · Cited by 165
Epigenetic Remodeling in Innate Immunity and Inflammation
Zhang, Q., & Cao, X. (2021) · Annual Review of Immunology · doi:10.1146/annurev-immunol-093019-123619 · Cited by 162
Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection
Zhu, B., Wu, Y., Huang, S., Zhang, R., Son, Y. M., Li, C., Cheon, I. S., Gao, X., Wang, M., Yao, C., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.04.001 · Cited by 153
Drugs targeting various stages of the SARS-CoV-2 life cycle: Exploring promising drugs for the treatment of Covid-19
Ramarao, P., Joshi, G., & Jagadeesh, G. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109721 · Cited by 160
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study
Mahil, S. K., Dand, N., Mason, K. J., Yiu, Z. Z. N., Tsakok, T., Meynell, F., Coker, B., McAteer, H., Moorhead, L., Mackenzie, T., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.007 · Cited by 153
Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19
Kumar, R., Rathi, H., Haq, A., Wimalawansa, S. J., & Sharma, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198235 · Cited by 155
Immune responses during COVID-19 infection
Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 167
Novel insights on the pulmonary vascular consequences of COVID-19
Potus, F., Mai, V., Lebret, M., Malenfant, S., Breton-Gagnon, É., Lajoie, A. C., Boucherat, O., Bonnet, S., & Provencher, S. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00195.2020 · Cited by 160
Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies
Market, M., Angka, L., Martel, A. B., Bastin, D. J., Olanubi, O., Tennakoon, G., Boucher, D. M., Ng, J., Ardolino, M., & Auer, R. C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01512 · Cited by 158
SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition
Mullen, P. J., Garcia, G., Purkayastha, A., Matulionis, N., Schmid, E. W., Momcilovic, M., Sen, C., Langerman, J., Ramaiah, A., Shackelford, D. B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22166-4 · Cited by 149
Obesity as a Potential Predictor of Disease Severity in Young COVID‐19 Patients: A Retrospective Study
Deng, M., Qi, Y.-J., Deng, L.-P., Wang, H.-W., Xu, Y.-C., Li, Z., Meng, Z., Tang, J., & Dai, Z. (2020) · Obesity · doi:10.1002/oby.22943 · Cited by 118
Bacterial infections and patterns of antibiotic use in patients with COVID‐19
Neto, A. G. M., Lo, K. B., Wattoo, A., Salacup, G., Pelayo, J., DeJoy, R., Bhargav, R., Gul, F., Peterson, E. L., Albano, J., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26441 · Cited by 151
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
Daamen, A. R., Bachali, P., Owen, K. A., Kingsmore, K. M., Hubbard, E. L., Labonte, A. C., Robl, R. D., Shrotri, S., Grammer, A. C., & Lipsky, P. E. (2021) · Scientific Reports · doi:10.1038/s41598-021-86002-x · Cited by 151
Humoral- and T-Cell–Specific Immune Responses to SARS-CoV-2 mRNA Vaccination in Patients With MS Using Different Disease-Modifying Therapies
Tortorella, C., Aiello, A., Gasperini, C., Agrati, C., Castilletti, C., Ruggieri, S., Meschi, S., Matusali, G., Colavita, F., Farroni, C., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000013108 · Cited by 156
The Relevance of a Physical Active Lifestyle and Physical Fitness on Immune Defense: Mitigating Disease Burden, With Focus on COVID-19 Consequences
Filgueira, T. O., Castoldi, Â., Santos, L. E. R., de Amorim, G. J., Fernandes, M. S. D. S., Anastácio, W. D. L. D. N., Campos, E. Z., Santos, T. M., & Souto, F. O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.587146 · Cited by 163
A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations
Chakraborty, C., Sharma, A. R., Bhattacharya, M., & Lee, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.801522 · Cited by 154
Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells
Planès, R., Pinilla, M., Santoni, K., Hessel, A., Passemar, C., Lay, K., Paillette, P., Valadão, A. L. C., Robinson, K. S., Bastard, P., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.033 · Cited by 160
Interactions of SARS-CoV-2 with the Blood–Brain Barrier
Erickson, M. A., Rhea, E. M., Knopp, R. C., & Banks, W. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052681 · Cited by 155
COVID-19 vaccine: where are we now and where should we go?
Soleimanpour, S., & Yaghoubi, A. (2021) · Expert Review of Vaccines · doi:10.1080/14760584.2021.1875824 · Cited by 155
Factors associated with the presence of headache in hospitalized COVID-19 patients and impact on prognosis: a retrospective cohort study
Trigo-López, J., García‐Azorín, D., Planchuelo‐Gómez, Á., Martínez‐Pías, E., Talavera, B., Hernández‐Pérez, I., Valle‐Peñacoba, G., Campo, P. S., de Lera, M., Chavarría‐Miranda, A., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01165-8 · Cited by 145
RNA-induced liquid phase separation of SARS-CoV-2 nucleocapsid protein facilitates NF-κB hyper-activation and inflammation
Wu, Y., Ma, L., Cai, S., Zhuang, Z., Zhao, Z., Jin, S., Xie, W., Zhou, L., Zhang, L., Zhao, J., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00575-7 · Cited by 151
Immunological Implications of Physical Inactivity among Older Adults during the COVID-19 Pandemic
Damiot, A., Pinto, A. J., Turner, J. E., & Gualano, B. (2020) · Gerontology · doi:10.1159/000509216 · Cited by 153
SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4
Onodi, F., Bonnet‐Madin, L., Meertens, L., Karpf, L., Poirot, J., Zhang, S., Pïcard, C., Puel, A., Jouanguy, E., Zhang, Q., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201387 · Cited by 147
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
Cabral-Marques, O., Halpert, G., Schimke, L. F., Ostrinski, Y., Vojdani, A., Baiocchi, G. C., Freire, P. P., Filgueiras, I. S., Zyskind, I., Lattin, M. T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28905-5 · Cited by 144
Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients
Xu, Z.-S., Shu, T., Kang, L., Wu, D., Zhou, X., Liao, B.-W., Sun, X.-L., Zhou, X., & Wang, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0211-1 · Cited by 145
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
Chakravarty, D., Nair, S. S., Hammouda, N., Ratnani, P., Gharib, Y., Wagaskar, V. G., Mohamed, N., Lundon, D., Dovey, Z. S., Kyprianou, N., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-1088-9 · Cited by 145
The age distribution of mortality from novel coronavirus disease (COVID-19) suggests no large difference of susceptibility by age
Omori, R., Matsuyama, R., & Nakata, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-73777-8 · Cited by 141
Altered ISGylation drives aberrant macrophage-dependent immune responses during SARS-CoV-2 infection
Munnur, D., Teo, Q. W., Eggermont, D., Lee, H. H. Y., Théry, F., Ho, J., van Leur, S. W., Ng, W. W., Siu, L. Y.-L., Beling, A., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01035-8 · Cited by 139
Association of Neutrophil Activation, More Than Platelet Activation, With Thrombotic Complications in Coronavirus Disease 2019
Petito, E., Falcinelli, E., Paliani, U., Cesari, E., Vaudo, G., Sebastiano, M., Cerotto, V., Guglielmini, G., Gori, F., Malvestiti, M., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa756 · Cited by 141
The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
Abdelnabi, R., Foo, C. S.-Y., Kaptein, S. J. F., Zhang, X., Dan, T. N., Langendries, L., Vangeel, L., Breuer, J., Pang, J., Williams, R. J., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103595 · Cited by 141
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Hsu, R., Yu, W.-C., Peng, G.-R., Ye, C.-H., Hu, S., Chong, P. C. T., Yap, K. Y., Lee, J. Y. C., Lin, W., & Yu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.832394 · Cited by 148
Impact of Lung Segmentation on the Diagnosis and Explanation of COVID-19 in Chest X-ray Images
Teixeira, L. O., Pereira, R. M., Bertolini, D. S., Oliveira, L. S., Nanni, L., Cavalcanti, G. D. C., & Costa, Y. M. G. (2021) · Sensors · doi:10.3390/s21217116 · Cited by 152
The Role of Th17 Response in COVID-19
Martonik, D., Parfieniuk‐Kowerda, A., Rogalska, M., & Flisiak, R. (2021) · Cells · doi:10.3390/cells10061550 · Cited by 144
Macrophage activation syndrome and COVID-19
Otsuka, R., & Seino, K.-I. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00131-w · Cited by 139
Recurrent COVID-19 including evidence of reinfection and enhanced severity in thirty Brazilian healthcare workers
dos Santos, L. A., Filho, P. G. D. G., Silva, A. M. F., dos Santos, J. V. G., Santos, D. S., Aquino, M. M., de Jesus, R. M., Almeida, M. L. D., Silva, J. S., Altmann, D. M., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.01.020 · Cited by 136
Xuanfei Baidu Decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1/IL17A pathway
Wang, Y., Wang, X., Li, Y., Xue, Z., Shao, R., Li, L., Zhu, Y., Zhang, H., & Yang, J. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106083 · Cited by 139
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
Kohmer, N., Westhaus, S., Rühl, C., Ciesek, S., & Rabenau, H. F. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26145 · Cited by 138
A brief review of interplay between vitamin D and angiotensin‐converting enzyme 2: Implications for a potential treatment for COVID ‐19
Mahdavi, A. M. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2119 · Cited by 141
Targeting TMPRSS2 in SARS-CoV-2 Infection
Baughn, L. B., Sharma, N., Elhaik, E., Sekulić, A., Bryce, A. H., & Fonseca, R. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.06.018 · Cited by 141
Cell-free DNA maps COVID-19 tissue injury and risk of death and can cause tissue injury
Andargie, T. E., Tsuji, T., Seifuddin, F., Jang, M. K., Yuen, P. S. T., Kong, H., Tunc, I., Singh, K., Charya, A. V., Wilkins, K. J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147610 · Cited by 131
Cell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Li, Z., Wang, Y., Ding, Y., Repp, L., Kwon, G. S., & Hu, Q. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100088 · Cited by 138
COVID-19 and the role of cytokines in this disease
Hasanvand, A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00992-2 · Cited by 138
Impact of COVID-19 in solid organ transplant recipients
Danziger‐Isakov, L. A., Blumberg, E. A., Manuel, O., & Sester, M. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16449 · Cited by 139
StackIL6: a stacking ensemble model for improving the prediction of IL-6 inducing peptides
Charoenkwan, P., Chiangjong, W., Nantasenamat, C., Hasan, M. M., Manavalan, B., & Shoombuatong, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab172 · Cited by 134
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
Khoury, D. S., Wheatley, A. K., Ramuta, M. D., Reynaldi, A., Cromer, D., Subbarao, K., O’Connor, D. H., Kent, S. J., & Davenport, M. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00471-1 · Cited by 115
‘I can’t cope with multiple inputs’: a qualitative study of the lived experience of ‘brain fog’ after COVID-19
Callan, C., Ladds, E. C., Husain, L., Pattinson, K. T. S., & Greenhalgh, T. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056366 · Cited by 151
Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients
Oja, A. E., Saris, A., Ghandour, C. A., Kragten, N. A. M., Hogema, B. M., Nossent, E. J., Heunks, L. M. A., Cuvalay, S., Slot, E., Linty, F., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048908 · Cited by 145
The place for remdesivir in COVID-19 treatment
Young, B. E., Tan, T. T., & Leo, Y. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30911-7 · Cited by 133
Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity
Chakraborty, S., González, J. C., Sievers, B. L., Mallajosyula, V. V. A., Chakraborty, S., Dubey, M., Ashraf, U., Cheng, B. Y.-L., Kathale, N. D., Tran, K. Q. T., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm7853 · Cited by 137
Placental barrier against COVID-19
Komine‐Aizawa, S., Takada, K., & Hayakawa, S. (2020) · Placenta · doi:10.1016/j.placenta.2020.07.022 · Cited by 132
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)
Nițulescu, G. M., Păunescu, H., Moschos, S. A., Petrakis, D., Nițulescu, G., Ion, D., Spandidos, D. A., Νikolouzakis, Τ. Κ., Drakoulis, N., & Tsatsakis, A. M. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4608 · Cited by 135
Immunological co-ordination between gut and lungs in SARS-CoV-2 infection
Ahlawat, S., Asha, A., & Sharma, K. K. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198103 · Cited by 137
Melatonin potentials against viral infections including COVID-19: Current evidence and new findings
Juybari, K. B., Pourhanifeh, M. H., Hosseinzadeh, A., Hemati, K., & Mehrzadi, S. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198108 · Cited by 130
Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19
Liu, Y., Lv, J., Liu, J., Li, M., Xie, J., Lv, Q., Deng, W., Zhou, N., Zhou, Y., Song, J., et al. (2020) · Cell Research · doi:10.1038/s41422-020-00435-z · Cited by 130
Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment
Shah, S., Danda, D., Kavadichanda, C. G., Das, S., Adarsh, M. B., & Negi, V. S. (2020) · Rheumatology International · doi:10.1007/s00296-020-04639-9 · Cited by 130
Sex Disparities in COVID-19 Severity and Outcome: Are Men Weaker or Women Stronger?
Pivonello, R., Auriemma, R. S., Pivonello, C., Isidori, A. M., Corona, G., Colao, A. A. L., & Millar, R. P. (2020) · Neuroendocrinology · doi:10.1159/000513346 · Cited by 134
Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19
Vahedifard, F., & Chakravarthy, K. V. (2021) · Emergent Materials · doi:10.1007/s42247-021-00168-8 · Cited by 129
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
Wettstein, L., Weil, T., Conzelmann, C., Müller, J. A., Groß, R. M., Hirschenberger, M., Seidel, A., Klute, S., Zech, F., Bozzo, C. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21972-0 · Cited by 142
Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice
Zeng, J., Xie, X., Feng, X., Xu, L., Han, J.-B., Yu, D., Zou, Q., Liu, Q., Li, X., Ma, G., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103803 · Cited by 130
Increased IL-8, Neutrophil Activation Phenotypes and NETosis in Critically Ill COVID-19 Patients
Masso-Silva, J. A., Moshensky, A., Lam, M. T. Y., Odish, M. F., Patel, A., Xu, L., Hansen, E. A., Trescott, S., Nguyen, C. T., Kim, R. Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciab437 · Cited by 128
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
Mercurio, I., Tragni, V., Busto, F., Grassi, A., & Pierri, C. L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03580-1 · Cited by 129
Computer-aided prediction and design of IL-6 inducing peptides: IL-6 plays a crucial role in COVID-19
Dhall, A., Patiyal, S., Sharma, N., Usmani, S. S., & Raghava, G. P. S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa259 · Cited by 124
COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
Hunt, R. H., East, J. E., Lanas, Á., Malfertheiner, P., Satsangi, J. J., Scarpignato, C., & Webb, G. J. (2020) · Digestive Diseases · doi:10.1159/000512152 · Cited by 126
COVID-19 Hyperinflammation: What about Neutrophils?
Didangelos, A. (2020) · mSphere · doi:10.1128/msphere.00367-20 · Cited by 125
The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies
Ferrandi, P. J., Alway, S. E., & Mohamed, J. S. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00321.2020 · Cited by 124
Impact of the COVID-19 pandemic on clinical research
Tuttle, K. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00336-9 · Cited by 126
Circulating Endothelial Cells as a Marker of Endothelial Injury in Severe COVID -19
Guervilly, C., Burtey, S., Sabatier, F., Cauchois, R., Lano, G., Abdili, E., Daviet, F., Arnaud, L., Brunet, P., Hraiech, S., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa528 · Cited by 129
The role of Interleukin 6 inhibitors in therapy of severe COVID-19
Nasonov, E. L., & MIu, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110698 · Cited by 126
“The pathogenetic mechanisms of COVID-19 are summarized in a series of reviews [8,9].”
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
Sadeghı, A., Asgari, A., Norouzi, A., Kheiri, Z., Anushirvani, A., Montazeri, M., Hosamirudsai, H., Afhami, S., Akbarpour, E., Aliannejad, R., et al. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa334 · Cited by 125
Sharing CD4+ T Cell Loss: When COVID-19 and HIV Collide on Immune System
Peng, X., Ouyang, J., Isnard, S., Lin, J. C.-Y., Fombuena, B., Zhu, B., & Routy, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.596631 · Cited by 126
The role of IL-6 and IL-6 blockade in COVID-19
Potere, N., Batticciotto, A., Vecchié, A., Porreca, E., Cappelli, A., Abbate, A., Dentali, F., & Bonaventura, A. (2021) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1919086 · Cited by 127
Nutritional status, diet and viral respiratory infections: perspectives for severe acute respiratory syndrome coronavirus 2
Morais, A. H. D. A., Aquino, J. D. S., da Silva-Maia, J. K., Vale, S. H. D. L., Maciel, B. L. L., & Passos, T. S. (2020) · British Journal Of Nutrition · doi:10.1017/s0007114520003311 · Cited by 127
COVID-19–associated multisystem inflammatory syndrome in children (MIS-C): A novel disease that mimics toxic shock syndrome—the superantigen hypothesis
Rivas, M. N., Porritt, R. A., Cheng, M. H., Bahar, İ., & Arditi, M. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.10.008 · Cited by 122
Building a Resilient, Sustainable, and Healthier Food Supply Through Innovation and Technology
McClements, D. J., Barrangou, R., Hill, C., Kokini, J. L., Lila, M. A., Meyer, A. S., & Yu, L. L. (2020) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-092220-030824 · Cited by 142
SARS-CoV-2 mediated neuroinflammation and the impact of COVID-19 in neurological disorders
Amruta, N., Chastain, W. H., Paz, M., Solch-Ottaiano, R. J., Murray-Brown, I. C., Befeler, J. B., Gressett, T. E., Longo, M. T., Engler-Chiurazzi, E. B., & Bix, G. J. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2021.02.002 · Cited by 123
Association of COVID ‐19 with impaired endothelial glycocalyx, vascular function and myocardial deformation 4 months after infection
Lambadiari, V., Mitrakou, A., Kountouri, A., Thymis, J., Katogiannis, K., Korakas, E., Varlamos, C., Andreadou, I., Tsoumani, M. E., Triantafyllidi, H., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2326 · Cited by 121

Authors: Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P.
Affiliations: Agency for Science, Technology and Research (SG)
National University of Singapore (SG)
Corresponding author: Rénia, Laurent
MacAry, Paul A.
Ng, Lisa F. P.
ORCID: Tay, Matthew Zirui
Poh, Chek Meng
Rénia, Laurent
MacAry, Paul A.
Ng, Lisa F. P.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2020-04-28
Volume: 20
Issue: 6
Pages: 363-374
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/s41577-020-0311-8
PMC: PMC7187672
OpenAlex: W3018517500
Cited by: 4,360
References: 136
Citations by year: 2026: 82 · 2025: 169 · 2024: 320 · 2023: 552 · 2022: 899 · 2021: 1369 · 2020: 961
FWCI: 44.76
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
Funders: Medical Research Council
Biomedical Research Council
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
Keywords: SARS-CoV-2, COVID-19 pandemic, immune response, inflammation, pathophysiology, immune dysregulation, SARS-CoV, MERS-CoV, lower respiratory tract infection, immune regulation, antiviral therapy, therapeutic interventions
MeSH terms: Betacoronavirus, COVID-19, SARS-CoV-2, Animals, Humans, Inflammation, Pneumonia, Viral, Coronavirus Infections, Disease Progression, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The trinity of COVID-19: immunity, inflammation and intervention

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks